These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8309265)

  • 1. Immunomagnetic separation of subpopulations of apolipoprotein A-I.
    Rastogi A; Bren ND; Hallaway BJ; Kottke BA
    Mayo Clin Proc; 1994 Feb; 69(2):137-43. PubMed ID: 8309265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL subparticles and coronary artery disease in NIDDM.
    O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Kottke BA
    Atherosclerosis; 1996 Apr; 121(2):285-91. PubMed ID: 9125302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-II levels and coronary artery disease in subjects with and without diabetes: a study with use of a specific radioimmunoassay for apolipoprotein A-II.
    Wentworth MA; O'Brien T; Rastogi A; Kottke BA
    Mayo Clin Proc; 1993 Jun; 68(6):556-60. PubMed ID: 8098786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations.
    James RW; Pometta D
    Atherosclerosis; 1990 Jul; 83(1):35-45. PubMed ID: 2117929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects.
    Tilly-Kiesi M; Lichtenstein AH; Joven J; Vilella E; Cheung MC; Carrasco WV; Ordovas JM; Dolnikowski G; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3513-8. PubMed ID: 9437200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-I containing lipoproteins in coronary artery disease.
    Puchois P; Kandoussi A; Fievet P; Fourrier JL; Bertrand M; Koren E; Fruchart JC
    Atherosclerosis; 1987 Nov; 68(1-2):35-40. PubMed ID: 3120739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein AI- and AI:AII-containing lipoproteins in white men and women of the HERITAGE Family study: Associations with metabolic risk profile variables.
    Couillard C; Bergeron J; Després JP; Gagnon J; Rankinen T; Leon AS; Rao DC; Skinner JS; Wilmore JH; Bouchard C
    Metabolism; 2003 Dec; 52(12):1530-6. PubMed ID: 14669150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of apolipoprotein AI-containing lipoprotein particles in non-insulin-dependent diabetes mellitus.
    Contiero E; Ferrari R; Vaselli GM; Folin M
    Diabetes Res Clin Pract; 1998 Mar; 39(3):201-9. PubMed ID: 9649952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of LpAI lipoparticles, HDL cholesterol and apolipoprotein AI in a control population, in a group of subjects with coronary diseases, and in a group of subjects with angiographically normal coronary vessels].
    Ardissone JP; Cohen-Billiemaz A; Heim M; Gulian JM; Giordanella JP; Bory M; Charrel M
    Ann Biol Clin (Paris); 1992; 50(3):149-53. PubMed ID: 1456494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
    Cheung MC; Mendez AJ; Wolf AC; Knopp RH
    J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII.
    James RW; Pometta D
    J Lipid Res; 1994 Sep; 35(9):1583-91. PubMed ID: 7806972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.
    Wilund KR; Colvin PL; Phares D; Goldberg AP; Hagberg JM
    Metabolism; 2002 Aug; 51(8):1053-60. PubMed ID: 12145781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
    Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
    J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.
    Kido T; Kondo K; Kurata H; Fujiwara Y; Urata T; Itakura H; Yokoyama S
    Lipids Health Dis; 2017 Nov; 16(1):225. PubMed ID: 29187200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study).
    Luc G; Bard JM; Evans A; Arveiler D; Ruidavets JB; Amouyel P; Ducimetiere P
    Atherosclerosis; 2000 Oct; 152(2):399-405. PubMed ID: 10998468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LpAI in HDL subfractions: serum levels in men and women with coronary heart disease and changes under hypolipemic therapy.
    Nowicka G; Jarosz A
    Clin Chim Acta; 2001 Apr; 306(1-2):43-9. PubMed ID: 11282093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein AIV of human interstitial fluid is associated with apolipoprotein AI-containing but not with AII-containing particles.
    Ghalim N; Adlouni A; Saile R; Parra HJ; Benslimane A; Bard JM; Fruchart JC
    Int J Clin Lab Res; 1996; 26(4):224-8. PubMed ID: 9007611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triiodothyronine exerts a major pleiotropic effect on reverse cholesterol transport phenotypes.
    Comuzzie AG; Blangero J; Mahaney MC; Sharp RM; VandeBerg JL; Stern MP; MacCluer JW
    Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):289-93. PubMed ID: 8620345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.
    Barkia A; Puchois P; Ghalim N; Torpier G; Barbaras R; Ailhaud G; Fruchart JC
    Atherosclerosis; 1991 Apr; 87(2-3):135-46. PubMed ID: 1906713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.